Covance, Inc. (CVD) Reports In-Line Q3 EPS; Issues Light EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 rises as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Investors Too Bearish on Laboratory Corp (LH)/ Covance (CVD) Deal, Says Deutsche Bank
November 3, 2014 12:59 PM ESTDeutsche Bank maintained a Buy rating on Laboratory Corporation of America (NYSE: LH) and raised its price target to $120.00 (from $116.00). Analyst Darren Lehrich thinks investors are too negative on its Covance, Inc. (NYSE: CVD) deal.
"LH... More
LabCorp (LH) to Acquire Covance (CVD) in $6.1B Cash and Stock Deal
November 3, 2014 6:07 AM ESTLaboratory Corporation of America Holdings (NYSE: LH) entered into a definitive agreement to acquire Covance Inc. (NYSE: CVD) for $105.12 per Covance share in cash and stock, or an equity value of approximately $6.1 billion and an enterprise value of approximately $5.6 billion.
The combination will create the worlds leading healthcare diagnostics company, capitalizing on LabCorps industry leadership in medical testing and Covances leadership in contract research.
Under the terms of the agreement, which has been approved by the Boards of Directors of both companies, Covance shareholders will... More
